LAURUSLABSstockLaurus Labs Ltd
₹1,368.95
▼-0.51%
Open
₹1,389.3
High
₹1,389.3
Low
₹1,357.6
Volume
1.10M
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹602.32026-06-18 · ₹1,359.15
Instrument details
- MB Code
- MBEQU222
- Type
- stock
- ISIN
- INE947Q01028
- BSE
- 540222
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 1811.57 Cr
- Net profit
- 281.91 Cr
- EPS
- 5.17
- YoY revenue
- +5.31%
Price returns
Historical performance
- 1 day
- -0.72%
- 1 month
- +1.05%
- 3 months
- +37.74%
- 1 year
- +104.88%
- 3 years
- +272.83%
- 5 years
- +129.14%
Technicals
Indicator consensus
Bullish
22
Neutral
6
Bearish
18
RSI 33.51(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
78Investor presentations
84Corporate announcements
275Corporate timeline
Price chart events · 1 year
Dividend
2025-10-31
{"amount":0.8}
Dividend
2026-05-08
{"amount":1.2}
Earnings
2025-10-23
{"actualRevenue":16534700000,"estimateRevenue":15416000000,"revenueSurprise":1118700000,"revenueSurprisePercent":7.256746237675142,"actualEPS":3.61,"estimateEPS":2.5347,"surprise":1.0753,"surprisePercent":42.42316644967846}
Earnings
2025-07-25
{"actualRevenue":15695700000,"estimateRevenue":14751000000,"revenueSurprise":944700000,"revenueSurprisePercent":6.404311572096807,"actualEPS":3.02,"estimateEPS":2.2848,"surprise":0.7351999999999999,"surprisePercent":32.17787114845937}
Earnings
2026-01-23
{"actualRevenue":17782900000,"estimateRevenue":16809000000,"revenueSurprise":973900000,"revenueSurprisePercent":5.793919923850319,"actualEPS":4.67,"estimateEPS":3.774,"surprise":0.8959999999999995,"surprisePercent":23.74138844727078}
Earnings
2026-04-30
{"actualRevenue":18115700000,"estimateRevenue":19375000000,"revenueSurprise":-1259300000,"revenueSurprisePercent":-6.499612903225807,"actualEPS":5.17,"estimateEPS":5.123796599999999,"surprise":0.04620340000000045,"surprisePercent":0.9017414937977916}
News
2026-05-14
{"description":"Laurus Labs shares fell after weak Q3 results, with investors debating whether the stock is still worth holding or selling following the disappointing quarterly performance.","url":"https://www.zeebiz.com/markets/stocks/news-laurus-labs-share-price-nse-bse-price-target-q3-results-profit-margin-revenue-273506","sentiment":"Negative","domain":"Zee Business"}
News
2026-05-04
{"description":"Laurus Labs jumped 6% to a record high after Q4 results, with brokerages turning upbeat as CDMO quarterly run rate rose from ₹220-250 crore to ₹450-500 crore.","url":"https://www.business-standard.com/markets/news/laurus-labs-rallies-6-hits-record-high-post-q4-results-brokerages-upbeat-126050400334_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2026-04-30
{"description":"Laurus Labs reported Q4 results with net profit up 19% year-on-year to ₹279 crore, indicating improved profitability for the quarter.","url":"https://www.thehindubusinessline.com/companies/laurus-labs-q4-results-net-profit-rises-19-to-279-cr/article70924434.ece","sentiment":"Positive","domain":"The Hindu BusinessLine"}
News
2026-03-30
{"description":"Laurus Labs’ consolidated net profit rose 19.46% in the March 2026 quarter; FY net profit jumped 148.04% to Rs 888.79 crore and sales rose 22.67% to Rs 6,812.90 crore.","url":"https://www.business-standard.com/markets/capital-market-news/laurus-labs-consolidated-net-profit-rises-19-46-in-the-march-2026-quarter-126043000938_1.html","sentiment":"Positive","domain":"Business Standard"}